[go: up one dir, main page]

FI862029A7 - Askorbinsyraderivat, deras framställning och användning. - Google Patents

Askorbinsyraderivat, deras framställning och användning. Download PDF

Info

Publication number
FI862029A7
FI862029A7 FI862029A FI862029A FI862029A7 FI 862029 A7 FI862029 A7 FI 862029A7 FI 862029 A FI862029 A FI 862029A FI 862029 A FI862029 A FI 862029A FI 862029 A7 FI862029 A7 FI 862029A7
Authority
FI
Finland
Prior art keywords
preparation
ascorbic acid
acid derivatives
derivatives
ascorbic
Prior art date
Application number
FI862029A
Other languages
English (en)
Finnish (fi)
Other versions
FI862029L (fi
FI862029A0 (fi
Inventor
Shinji Terao
Minoru Hirata
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1985/000272 external-priority patent/WO1986006720A1/ja
Priority claimed from PCT/JP1985/000340 external-priority patent/WO1986007592A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI862029A0 publication Critical patent/FI862029A0/fi
Publication of FI862029A7 publication Critical patent/FI862029A7/sv
Publication of FI862029L publication Critical patent/FI862029L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
FI862029A 1985-05-17 1986-05-14 Askorbinsyraderivat, deras framstaellning och anvaendning. FI862029L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP1985/000272 WO1986006720A1 (fr) 1985-05-17 1985-05-17 Derives d'acide ascorbique, production desdits derives et preparation pharmaceutique pouvant en resulter
PCT/JP1985/000340 WO1986007592A1 (fr) 1985-06-18 1985-06-18 Derives d'acide ascorbique, leur procede de preparation, et preparations les contenant

Publications (3)

Publication Number Publication Date
FI862029A0 FI862029A0 (fi) 1986-05-14
FI862029A7 true FI862029A7 (sv) 1986-11-18
FI862029L FI862029L (fi) 1986-11-18

Family

ID=26425982

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862029A FI862029L (fi) 1985-05-17 1986-05-14 Askorbinsyraderivat, deras framstaellning och anvaendning.

Country Status (17)

Country Link
EP (1) EP0202589B1 (sv)
JP (1) JPH0739342B2 (sv)
KR (1) KR940000073B1 (sv)
CN (1) CN1014409B (sv)
AU (1) AU599029B2 (sv)
CA (1) CA1293728C (sv)
DE (1) DE3669104D1 (sv)
ES (1) ES8801643A1 (sv)
FI (1) FI862029L (sv)
GR (1) GR861228B (sv)
HU (1) HU197735B (sv)
IE (1) IE59143B1 (sv)
IL (1) IL78739A (sv)
NO (1) NO172343C (sv)
PH (1) PH24833A (sv)
PT (1) PT82591B (sv)
ZA (1) ZA852614B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2515556B2 (ja) * 1986-08-29 1996-07-10 武田薬品工業株式会社 ヒドロキシブテノライド誘導体およびその製造法
US4826872A (en) * 1986-12-03 1989-05-02 Takeda Chemical Industries, Ltd. Pharmaceutical composition for treatment of cataract
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
JP2752080B2 (ja) * 1988-03-09 1998-05-18 株式会社日本ハイポックス アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤
JPH0730066B2 (ja) * 1988-03-09 1995-04-05 株式会社日本ハイポックス アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤
JPH01228978A (ja) * 1988-03-09 1989-09-12 Nippon Hai Potsukusu:Kk アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤
IL89850A0 (en) * 1988-04-25 1989-12-15 Takeda Chemical Industries Ltd Ester of ascorbic acid 2-phosphate
JP2830268B2 (ja) * 1989-01-21 1998-12-02 武田薬品工業株式会社 アスコルビン酸誘導体の製造法
US5270336A (en) * 1990-03-16 1993-12-14 Merrell Dow Pharmaceuticals Inc. Ascorbic acid derivatives
EP0446539A1 (en) * 1990-03-16 1991-09-18 Merrell Dow Pharmaceuticals Inc. Novel ascorbic acid derivatives
EP0467691A1 (en) * 1990-07-20 1992-01-22 Takeda Chemical Industries, Ltd. Saccharoascorbic acid derivatives and their use
AU2267992A (en) * 1991-08-27 1993-03-16 Upjohn Company, The Compounds used for the inhibition of hiv-protease
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
AU7636894A (en) * 1993-09-17 1995-04-03 Upjohn Company, The Substituted tetronic acids useful for treating hiv and other retroviruses
JPH07188024A (ja) * 1993-12-27 1995-07-25 Asahi Breweries Ltd 脳循環障害治療剤
FR2715156B1 (fr) * 1994-01-20 1996-03-01 Oreal Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
US6060600A (en) * 1995-03-20 2000-05-09 Pharmacia & Upjohn Company Substituted tetronic acids useful for treating HIV and other retroviruses
AU5317296A (en) * 1995-03-24 1996-10-16 Francis V. Defeudis Methods for treating conditions associated with excess nitri c oxide
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
KR100440190B1 (ko) * 2001-08-23 2004-07-12 박관화 아카비오신-글루코실 아스코르베이트 및 그의 제조방법
KR100440191B1 (ko) * 2001-08-23 2004-07-12 박관화 항산화 효과 및 높은 안정성을 갖는 아스코르브산 유도체및 그것의 제조방법
CN1805948A (zh) * 2003-04-21 2006-07-19 塔格拉生物科技有限公司 抗坏血酸的稳定衍生物
FR2946252B1 (fr) * 2009-06-08 2011-07-29 Fabre Pierre Dermo Cosmetique Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques
JP6020447B2 (ja) * 2011-05-18 2016-11-02 三菱瓦斯化学株式会社 酸素吸収剤
FR2978963A1 (fr) 2011-08-11 2013-02-15 Ascorbix Nouveaux derives des furanones et composition pharmaceutique les contenant
WO2014050894A1 (ja) * 2012-09-27 2014-04-03 日本曹達株式会社 アスコルビン酸類縁化合物および抗植物ウイルス剤
JP6872548B2 (ja) * 2015-12-03 2021-05-19 スリーエム イノベイティブ プロパティズ カンパニー 光解離性還元剤を有するレドックス重合性組成物
EP3630903B1 (en) 2017-05-24 2020-10-07 3M Innovative Properties Company Adhesive article and methods of making and using the same
JP6986375B2 (ja) * 2017-06-22 2021-12-22 章博 田井 抗アレルギー剤、メディエーター遊離阻害剤及び内服薬
JP7140325B2 (ja) 2018-05-23 2022-09-21 株式会社らいむ 化合物、抗アレルギー剤およびメディエーター遊離阻害剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1016834A (en) * 1962-11-26 1966-01-12 Nihon Surfactant Ind Company L Improvements in or relating to 2.6 diesters of ascorbic acid or isoascorbic acid
DE1518988A1 (de) * 1965-05-07 1969-12-11 Herbert Ohg A Verfahren zur Herstellung von Di- und Triestern der Ascorbinsaeure
JPS49833B1 (sv) * 1970-09-01 1974-01-10
JPS4867268A (sv) * 1971-12-20 1973-09-13
JPS5719109B2 (sv) * 1973-07-19 1982-04-20
US4164585A (en) * 1976-07-01 1979-08-14 Cardioquest Corporation Anti-thrombotic compound and method of making and using the same for pharmaceutical purposes
JPS5692260A (en) * 1979-12-26 1981-07-25 Nippon Chemiphar Co Ltd Cyclohexanecarboxylic ester and its preparation
JPS57156479A (en) * 1981-03-24 1982-09-27 Santen Pharmaceut Co Ltd Ascorbic acid derivative
JPS601175A (ja) * 1983-06-16 1985-01-07 Daikin Ind Ltd アスコルビン酸誘導体
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
JPS60237083A (ja) * 1984-05-08 1985-11-25 Kao Corp アスコルビン酸エステル

Also Published As

Publication number Publication date
ES8801643A1 (es) 1988-02-16
NO172343C (no) 1993-07-07
PT82591B (pt) 1988-11-30
DE3669104D1 (de) 1990-04-05
KR860009001A (ko) 1986-12-19
GR861228B (en) 1986-09-15
AU599029B2 (en) 1990-07-12
ZA852614B (en) 1986-10-09
EP0202589A3 (en) 1987-10-07
PT82591A (en) 1986-06-01
HU197735B (en) 1989-05-29
IL78739A0 (en) 1986-08-31
EP0202589A2 (en) 1986-11-26
ES555014A0 (es) 1988-02-16
CA1293728C (en) 1991-12-31
NO172343B (no) 1993-03-29
PH24833A (en) 1990-10-30
IL78739A (en) 1993-01-31
NO861956L (no) 1986-11-18
JPS61263969A (ja) 1986-11-21
EP0202589B1 (en) 1990-02-28
FI862029L (fi) 1986-11-18
CN86103398A (zh) 1986-12-03
HUT44249A (en) 1988-02-29
FI862029A0 (fi) 1986-05-14
AU5735086A (en) 1986-11-20
IE59143B1 (en) 1994-01-12
IE861313L (en) 1986-11-17
JPH0739342B2 (ja) 1995-05-01
CN1014409B (zh) 1991-10-23
KR940000073B1 (ko) 1994-01-05

Similar Documents

Publication Publication Date Title
FI862029A7 (sv) Askorbinsyraderivat, deras framställning och användning.
FI853626A7 (sv) Isoxazolkarboxylsyraderivat, deras framställning och användning.
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
FI871419A7 (sv) Kinolin-3-karboxylsyraderivat, deras framställning och användning
FI870582A7 (sv) Aminouretaner, deras framställningsförfarande och deras användning
FI831457A7 (sv) 1-sulfo-2-azetidinon derivat, deras framställning och användning.
FI824314A7 (sv) Thienopyrimidin-derivater, deras framställning och deras medicinska användning.
TR22532A (tr) Piridazinon tuerevleri,bunlarin hazirlanmasi ve ensektisid,akarisid nematisid fungisid bilesikleri
DE3680773D1 (de) Isoxazolonaphthyridin-, isoxazolochinolin-, isothiazolonaphthyridin- und isothiazolochinolinderivate.
NL970029I2 (nl) Benzimidazoolderivaten, bereiding en therapeutische toepassing.
DE3667786D1 (de) Substituierte naphthalinderivate.
FI860369A7 (sv) Imidazolderivat, deras framställning och användning samt dessa derivat innehållande farmaceutiska kompositioner.
FI892675A7 (sv) 2,6-dihalogenpyridin-3-karboxylsyraderivat och deras framställning
FI820509A7 (sv) Nya azepinderivater, deras framställning och deras användning såsom läkemedel.
FI885592A7 (sv) Aryloxifenylpropylaminer, deras framställning och användning
FI801168A7 (sv) Derivater av penem-3-karbokxylsyra, deras framställning och användning.
FI860556A7 (sv) Nya 1,8-naftyridinderivat och förfarande för deras framställning.
FI863480A7 (sv) Azolyl-cyklopropyl-etanolderivat, förfarande för deras framställning och deras användning.
FI850266A7 (sv) Azolylarylalkanolderivat, förfarande för deras framställning och deras användning.
FI852657A7 (sv) Heterocykliska farmaceutiska föreningar framställning och användning.
IT1203816B (it) Disaccaridi,loro preparazione e loro impiego come medicamenti
FI861526A7 (sv) Derivat av nitrofuran, deras framställning och tillämpning i terapi.
FI853621A7 (sv) Vinyltetrasolylfenyl-derivat, deras framställning och användning.
FI870669A7 (sv) Nya derivat av 2-cyano-bensimidazol, deras framställning och användning som fungicider, deras kombinering med andra fungicider.
FI864566A7 (sv) Nitroantracykliner, förfarande för deras framställning och deras användning.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.